Revolution Medicines (42Z) Income Statement
Revolution Medicines Income Statement
Last quarter (Q2 2026), Revolution Medicines's total revenue was $0.00. In Q2, Revolution Medicines's net income was $-644.37M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 11.58M | $ 35.38M | $ 29.39M | |
| $ -16.56M | $ 0.00 | $ 11.58M | $ 35.38M | $ 29.39M | |
| $ 1.17B | $ 689.52M | $ 498.76M | $ 293.66M | $ 217.40M | |
| Depreciation and Amortization | $ 16.56M | $ 11.82M | $ 9.31M | $ 9.66M | $ 7.33M |
| $ -1.09B | $ -589.02M | $ -430.28M | $ -239.47M | $ -179.75M | |
| $ -1.18B | $ -689.52M | $ -487.19M | $ -258.28M | $ -188.01M | |
| $ 51.07M | $ 88.68M | $ 47.29M | $ 9.15M | $ 917.00K | |
| $ -1.13B | $ -600.85M | $ -439.89M | $ -249.13M | $ -187.09M | |
| $ -1.13B | $ -600.09M | $ -436.37M | $ -248.71M | $ -187.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.95 | $ -3.58 | $ -3.86 | $ -3.08 | $ -2.47 |
| Diluted EPS | $ -5.95 | $ -3.58 | $ -3.86 | $ -3.08 | $ -2.47 |
| Weighted Average Shares Outstanding | 190.13M | 167.74M | 113.15M | 80.63M | 72.81M |
| Weighted Average Shares Outstanding (Diluted) | 190.13M | 167.74M | 113.15M | 80.63M | 72.81M |
Currency in USD